期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

芪苈强心胶囊治疗慢性心力衰竭45例效果分析 被引量：6

原文传递
导出
摘要 目的观察芪苈强心胶囊治疗慢性心力衰竭(chronic heart failure,CHF)的临床效果。方法选择2010年1月—2011年6月收治的CHF患者90例,随机分为芪苈强心组和对照组各45例,两组患者均给予常规抗心力衰竭治疗,芪苈强心组加用芪苈强心胶囊4粒,3次/d,1个月。比较两组治疗前后左心射血分数(Left ventricular ejection fraction,LVEF)、生活质量指数问卷(quality of life index,QL-index)评分、6个月内再入院率及死亡率。结果治疗1个月后LVEF芪苈强心组(52.9±5.1)%,对照组(41.2±4.8)%,两组比较差异有统计学意义(P<0.05);QL-INDEX评分芪苈强心组(8.05±2.07)分,对照组(7.24±1.64)分,两组比较差异有统计学意义(均P<0.05)。结论芪苈强心胶囊治疗CHF安全有效,值得临床推广使用。
作者 文媛 兰为群 刘如泉
机构地区 武汉市汉口医院心内科
出处 《社区医学杂志》 2012年第21期29-30,共2页 Journal Of Community Medicine
关键词 芪苈强心胶囊 慢性心力衰竭 左心射血分数 生活质量指数问卷
分类号 R541.6 [医药卫生—心血管疾病]
  • 相关文献

参考文献10

二级参考文献44

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量：90
  • 2Imdal A,Stoylen A,Torp H,et al.Real-time strain rate imaging of the left ventricle by ultrasound[J].J Am Soc.Echocardiogr,1998,11:1013-1019.
  • 3周永昌,郭万学.超声医学[M].北京:科学技术文献出版社,2004:680-712.
  • 4Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 5Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 6Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 7Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 8Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 9Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 10Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.

共引文献4926

同被引文献68

  • 1XIAO H, SONG Y, LI Y, et al. Qiliqiangxin regu- lates the balance between tumor necrosis factor-a and interleukin-10 and improves cardiac function in rats with myocardial infarction[J]. Cell Immunol, 2009, 260:51-55.
  • 2ZOU Y, LIN L, YE Y, et al. Qiliqiangxin inhibits the development of cardiac hypertrophy, remodeling, and dysfunction during 4 weeks of pressure overload in mice[J]. Cardiovasc Pharmacol, 2012, 59: 268 - 280.
  • 3LIU W, CHEN J, XU T, et al. Qiliqiangxin im- proves cardiac function in spontaneously hypertensive rats through the inhibition of cardiac chymase[J]. Am J Hypertens,2012,25 : 250- 260.
  • 4WEI Y, LIU X, HOU L, et al. Qiliqiangxin affects L type Ca2+ current in the normal and hypertrophied rat heart[J]. Evid Based Complement Ahernat Med, 2012,2012:131830.
  • 5LI X, ZHANG J, HUANG J, et al. A multicenter randomized double-blind parallel-group placebo-con- trolled study of the effects of qili qiangxin capsules in patients with chronic heart failure[J]. J Am Coll Car- diol,2013 : S0735.
  • 6梁国钦,戴兆燕,廖华.不同疗程芪苈强心胶囊治疗慢性充血性心力衰竭患者的安全性评价[J].中国保健营养(中旬刊),2012,6(6):321-322.
  • 7WANG L, ZHOU G B, LIU P, et al. Dissection of mechanisms of Chinese medicinal formula Realgavln digo naturalis as an effective treatment for promyelo- cytic leukemia[J]. Proc Natl Acad Sci USA, 2008, 105:4826-4831.
  • 8ZHANG L, LIU Y, LU X T, et al. Traditional Chi- nese medication Tongxinluo dose-dependently en- hances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy[J]. Am J Physi- ol Heart Circ Physiol, 2009,297 : H2004- 2014.
  • 9LI X D, YANG Y J, GENG Y J, et al. Tongxinluo reduces myocardial no-reflow and ischemia-reperfusion injury by stimulating the phosphorylation of eNOS via the PKA pathway[J]. American journal of physiology[J]. Am J Physiol Heart Circ Physiol, 2010, 299: H1255-1261.
  • 10HU J, LIU Y F, WU C F, et al. Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide- based therapy in newly diagnosed acute promyelocytic leukemia[J]. Proc Natl Acad Sci U S A, 2009,106: 3342-3347.

引证文献6

二级引证文献53

社区医学杂志
2012年 第21期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部